Measurement of plasma sphingosine 1-phosphate
Measurement of plasma sphingosine 1-phosphate
批准号:
08672635
负责人:
YATOMI Yutaka
金额:
$1.41万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997
中文摘要
尽管鞘氨醇1-磷酸(Sph-1-P)据报道参与多种细胞过程,并且这种生物活性鞘脂的生理作用已被强烈提出,但很少有研究表明在生理条件下人体样本(包括体液和细胞)中存在Sph-1-P。在这项研究中,我们确定了Sph-1-P是人类血浆和血清的正常成分。血浆和血清Sph-1-P水平为191 ([SY.+-])。[) 79和484 [](]SY.+-。[) 82pmol /ml(平均值)[][) SD,n=8)。此外,当对6名健康成人的配对血浆和血清样本进行Sph-1-P测量时,发现血清Sph-1-P/血浆Sph-1-P比值为2.65 (]SY.+-)。[) 1.26(平均值)[](SD)。在凝血过程中释放的Sph-1-P最有可能是来自血小板,因为血小板比其他血细胞更丰富地储存Sph-1-P,并在刺激时将其储存的部分Sph-1-P释放到细胞外。我们还研究了血浆中sph -1- p的相关代谢。[<@D13@>D1H] Sph在血浆中稳定且完全不被代谢,但在富血小板血浆中被迅速并入血小板并主要代谢为Sph-1- p。[<@D13@>D1H]发现血浆中Sph不变,表明血浆中不含降解Sph-1- p所需的酶。总之,血小板可以将Sph转化为Sph-1- p,并且是后者在血液中的储存场所。鉴于Sph-1-P的多种生物学作用,活化血小板释放Sph-1-P可能参与多种生理和病理生理过程,包括血栓形成、止血、动脉粥样硬化和伤口愈合。
英文摘要
Although sphingosine 1-phosphate (Sph-1-P) is reportedly involved in diverse cellular processes and the physiological roles of this bioactive sphingolipid have been strongly suggested, few studies have revealed the presence of Sph-1-P in human samples, including body fluids and cells, under physiological conditions. In this study, we identified Sph-1-P as a normal constituent of human plasma and serum. The Sph-1-P levels in plasma and serum were 191 (]SY.+-。[) 79 and 484 (]SY.+-。[) 82 pmol/ml (mean (]SY.+-。[) SD,n=8), respectively. Furthermore, when Sph-1-P was measured in paired plasma and serum samples obtained from 6 healthy adults, the serum Sph-1-P/plasma Sph-1-P ratio was found to be 2.65 (]SY.+-。[) 1.26 (mean (]SY.+-。[) SD). It is most likely that the source of discharged Sph-1-P during blood clotting is platelets, because platelets abundantly store Sph-1-P compared with other blood cells, and release part of their stored Sph-1-P extracellularly upon stimulation. We also studied Sph-1-P-related metabolism in plasma. [<@D13@>D1H] Sph was stable and not metabolized at all in plasma, but was rapidly incorporated into platelets and metabolized mainly to Sph-1-P in platelet-rich plasma. [<@D13@>D1H] Sph was found to be unchanged in plasma, revealing that plasma does not contain the enzymes needed for Sph-1-P degradation. In summary platelets can convert Sph into Sph-1-P,and are storage sites for the latter in the blood. In view of the diverse biological effects of Sph-1-P,the release of Sph-1-P from activated platelets may be involved in a variety of physiological and pathophysiological processes, including thrombosis, hemostasis, atherosclerosis and wound healing.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Yatomi, Y., Yamamura, Y., Ruan, F., Kume, S., Ozaki, Y., and Igarashi, Y.: "N,N-Dimethylsphingosine 1-phosphate activates human platelets." FEBSLett.417. 341-344 (1997)
Yatomi, Y.、Yamamura, Y.、Ruan, F.、Kume, S.、Ozaki, Y. 和 Igarashi, Y.:“N,N-二甲基鞘氨醇 1-磷酸可激活人血小板。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yutaka Yatomi: "Sphingosine 1-phosphate,a bioactive sphimgolipid abundantly stored in platelets,is a normal constituent of human plasma and serum" Journal of Biochemistry.
Yutaka Yatomi:“1-磷酸鞘氨醇是一种大量储存在血小板中的生物活性鞘脂,是人体血浆和血清的正常成分”《生物化学杂志》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yatomi Y: "Sphingosine 1-phosphate,a bioactive sphingolipid abundently stored in platelets,is a normal constituent of human plasma and serum" Journal of Biochemistry. 121. 969-973 (1997)
Yatomi Y:“1-磷酸鞘氨醇是一种大量储存在血小板中的生物活性鞘脂,是人体血浆和血清的正常成分”《生物化学杂志》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yatomi Y: "Sphingosine 1-phosphate,a,bioactive sphingolipid abundantly stored in platelets,is a normal constituent of human plasma and serum" Journal of Biochemistry. 121. 969-973 (1997)
Yatomi Y:“1-磷酸鞘氨醇,一种生物活性鞘脂,大量储存在血小板中,是人体血浆和血清的正常成分”《生物化学杂志》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yatomi Y: "N,N-Dimethylsphingosine 1-phosphate activates human platelets" FEBS Letters. 417. 341-344 (1997)
Yatomi Y:“N,N-二甲基鞘氨醇 1-磷酸激活人类血小板”FEBS 快报。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 6 条
Establishment of laboratory medicine of lipid mediators
-
批准号:22249017
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$18.8万
-
财政年份:2010
-
负责人:YATOMI Yutaka
-
依托单位:
Analysis of platele-derived bioactive substances : establishment of platelet biology and its application into laboratory medicine
-
批准号:18209020
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$20.05万
-
财政年份:2006
-
负责人:YATOMI Yutaka
-
依托单位:
The significance of lysophosphatidic acid in vascular biology and application of its measurement into laboratory medicine
-
批准号:16390162
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$3.84万
-
财政年份:2004
-
负责人:YATOMI Yutaka
-
依托单位:
The significance of sphingosine 1-phosphate in vascular biology and its application to laboratory
-
批准号:14370794
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$3.58万
-
财政年份:2002
-
负责人:YATOMI Yutaka
-
依托单位:
Regulation of neutrophil functions by platelets
-
批准号:10672174
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.86万
-
财政年份:1998
-
负责人:YATOMI Yutaka
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Sphingosine通路在肺癌发生的作用机制
-
批准号:82172565
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:邓炯
-
依托单位:
鞘氨醇衍生物靶向Cer-Sph-S1P调控乳腺癌他莫昔芬耐药及免疫抑制
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2019
-
负责人:孟琼
-
依托单位:
磷脂转运蛋白通过磷酸鞘氨醇1影响高密度脂蛋白抗动脉粥样硬化功能的分子机制
-
批准号:81070247
-
项目类别:面上项目
-
资助金额:33.0万元
-
批准年份:2010
-
负责人:秦树存
-
依托单位:
S1P介导骨髓间充质干细胞参与肝纤维化的机制研究
-
批准号:30971348
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2009
-
负责人:李丽英
-
依托单位: